What is TRIANA Biomedicines worth?
$258.0Mlast known valuation
TRIANA Biomedicines last raised $120.1M in its Later Stage VC (Series B) (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for TRIANA Biomedicines
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC (Series B) | $120.1M | ▮ | ▮ |
| Apr 2022 | Early Stage VC (Series A) | $110.0M | ▮ | ▮ |
How TRIANA Biomedicines's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For TRIANA Biomedicines, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is TRIANA Biomedicines worth?
- TRIANA Biomedicines's last known valuation is $258.0M.
- How much has TRIANA Biomedicines raised?
- TRIANA Biomedicines has raised $246.1M in total funding across 2 recorded rounds.
- When did TRIANA Biomedicines last raise?
- TRIANA Biomedicines last raised in Nov 2025 (Later Stage VC (Series B)), raising $120.1M.